Global Intravenous (IV) Solutions Market Insight and Forecast to 2026
The research team projects that the Intravenous (IV) Solutions market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
ICU Medical Inc. (U.S.)
Baxter (U.S.)
B. Braun Melsungen AG (Germany)
Grifols S.A. (Spain)
Fresenius Kabi AG (Germany)
Terumo Medical Corporation (Tokyo)
Amanta Healthcare (India)
By Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
By Application
Hospital & Clinics
Ambulatory
Home Care
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Intravenous (IV) Solutions 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Intravenous (IV) Solutions Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Intravenous (IV) Solutions Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Intravenous (IV) Solutions market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
ICU Medical Inc. (U.S.)
Baxter (U.S.)
B. Braun Melsungen AG (Germany)
Grifols S.A. (Spain)
Fresenius Kabi AG (Germany)
Terumo Medical Corporation (Tokyo)
Amanta Healthcare (India)
By Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
By Application
Hospital & Clinics
Ambulatory
Home Care
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Intravenous (IV) Solutions 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Intravenous (IV) Solutions Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Intravenous (IV) Solutions Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Intravenous (IV) Solutions market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Intravenous (IV) Solutions Revenue
1.4 Market Analysis by Type
1.4.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Peripheral Parenteral Nutrition
1.4.3 Total Parenteral Nutrition
1.5 Market by Application
1.5.1 Global Intravenous (IV) Solutions Market Share by Application: 2021-2026
1.5.2 Hospital & Clinics
1.5.3 Ambulatory
1.5.4 Home Care
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Intravenous (IV) Solutions Market Perspective (2021-2026)
2.2 Intravenous (IV) Solutions Growth Trends by Regions
2.2.1 Intravenous (IV) Solutions Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Intravenous (IV) Solutions Historic Market Size by Regions (2015-2020)
2.2.3 Intravenous (IV) Solutions Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Intravenous (IV) Solutions Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Intravenous (IV) Solutions Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Intravenous (IV) Solutions Average Price by Manufacturers (2015-2020)
4 INTRAVENOUS (IV) SOLUTIONS PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Intravenous (IV) Solutions Market Size (2015-2026)
4.1.2 Intravenous (IV) Solutions Key Players in North America (2015-2020)
4.1.3 North America Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.1.4 North America Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Intravenous (IV) Solutions Market Size (2015-2026)
4.2.2 Intravenous (IV) Solutions Key Players in East Asia (2015-2020)
4.2.3 East Asia Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.2.4 East Asia Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Intravenous (IV) Solutions Market Size (2015-2026)
4.3.2 Intravenous (IV) Solutions Key Players in Europe (2015-2020)
4.3.3 Europe Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.3.4 Europe Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Intravenous (IV) Solutions Market Size (2015-2026)
4.4.2 Intravenous (IV) Solutions Key Players in South Asia (2015-2020)
4.4.3 South Asia Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.4.4 South Asia Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Intravenous (IV) Solutions Market Size (2015-2026)
4.5.2 Intravenous (IV) Solutions Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.5.4 Southeast Asia Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Intravenous (IV) Solutions Market Size (2015-2026)
4.6.2 Intravenous (IV) Solutions Key Players in Middle East (2015-2020)
4.6.3 Middle East Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.6.4 Middle East Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Intravenous (IV) Solutions Market Size (2015-2026)
4.7.2 Intravenous (IV) Solutions Key Players in Africa (2015-2020)
4.7.3 Africa Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.7.4 Africa Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Intravenous (IV) Solutions Market Size (2015-2026)
4.8.2 Intravenous (IV) Solutions Key Players in Oceania (2015-2020)
4.8.3 Oceania Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.8.4 Oceania Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Intravenous (IV) Solutions Market Size (2015-2026)
4.9.2 Intravenous (IV) Solutions Key Players in South America (2015-2020)
4.9.3 South America Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.9.4 South America Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Intravenous (IV) Solutions Market Size (2015-2026)
4.10.2 Intravenous (IV) Solutions Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.10.4 Rest of the World Intravenous (IV) Solutions Market Size by Application (2015-2020)
5 INTRAVENOUS (IV) SOLUTIONS CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Intravenous (IV) Solutions Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Intravenous (IV) Solutions Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Intravenous (IV) Solutions Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Intravenous (IV) Solutions Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Intravenous (IV) Solutions Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Intravenous (IV) Solutions Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Intravenous (IV) Solutions Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Intravenous (IV) Solutions Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Intravenous (IV) Solutions Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Intravenous (IV) Solutions Consumption by Countries
5.10.2 Kazakhstan
6 INTRAVENOUS (IV) SOLUTIONS SALES MARKET BY TYPE (2015-2026)
6.1 Global Intravenous (IV) Solutions Historic Market Size by Type (2015-2020)
6.2 Global Intravenous (IV) Solutions Forecasted Market Size by Type (2021-2026)
7 INTRAVENOUS (IV) SOLUTIONS CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Intravenous (IV) Solutions Historic Market Size by Application (2015-2020)
7.2 Global Intravenous (IV) Solutions Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN INTRAVENOUS (IV) SOLUTIONS BUSINESS
8.1 ICU Medical Inc. (U.S.)
8.1.1 ICU Medical Inc. (U.S.) Company Profile
8.1.2 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product Specification
8.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Baxter (U.S.)
8.2.1 Baxter (U.S.) Company Profile
8.2.2 Baxter (U.S.) Intravenous (IV) Solutions Product Specification
8.2.3 Baxter (U.S.) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 B. Braun Melsungen AG (Germany)
8.3.1 B. Braun Melsungen AG (Germany) Company Profile
8.3.2 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product Specification
8.3.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Grifols S.A. (Spain)
8.4.1 Grifols S.A. (Spain) Company Profile
8.4.2 Grifols S.A. (Spain) Intravenous (IV) Solutions Product Specification
8.4.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Fresenius Kabi AG (Germany)
8.5.1 Fresenius Kabi AG (Germany) Company Profile
8.5.2 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product Specification
8.5.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Terumo Medical Corporation (Tokyo)
8.6.1 Terumo Medical Corporation (Tokyo) Company Profile
8.6.2 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product Specification
8.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Amanta Healthcare (India)
8.7.1 Amanta Healthcare (India) Company Profile
8.7.2 Amanta Healthcare (India) Intravenous (IV) Solutions Product Specification
8.7.3 Amanta Healthcare (India) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Intravenous (IV) Solutions (2021-2026)
9.2 Global Forecasted Revenue of Intravenous (IV) Solutions (2021-2026)
9.3 Global Forecasted Price of Intravenous (IV) Solutions (2015-2026)
9.4 Global Forecasted Production of Intravenous (IV) Solutions by Region (2021-2026)
9.4.1 North America Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.3 Europe Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.7 Africa Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.9 South America Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Intravenous (IV) Solutions by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Intravenous (IV) Solutions by Country
10.2 East Asia Market Forecasted Consumption of Intravenous (IV) Solutions by Country
10.3 Europe Market Forecasted Consumption of Intravenous (IV) Solutions by Countriy
10.4 South Asia Forecasted Consumption of Intravenous (IV) Solutions by Country
10.5 Southeast Asia Forecasted Consumption of Intravenous (IV) Solutions by Country
10.6 Middle East Forecasted Consumption of Intravenous (IV) Solutions by Country
10.7 Africa Forecasted Consumption of Intravenous (IV) Solutions by Country
10.8 Oceania Forecasted Consumption of Intravenous (IV) Solutions by Country
10.9 South America Forecasted Consumption of Intravenous (IV) Solutions by Country
10.10 Rest of the world Forecasted Consumption of Intravenous (IV) Solutions by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Intravenous (IV) Solutions Distributors List
11.3 Intravenous (IV) Solutions Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Intravenous (IV) Solutions Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Intravenous (IV) Solutions Revenue
1.4 Market Analysis by Type
1.4.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Peripheral Parenteral Nutrition
1.4.3 Total Parenteral Nutrition
1.5 Market by Application
1.5.1 Global Intravenous (IV) Solutions Market Share by Application: 2021-2026
1.5.2 Hospital & Clinics
1.5.3 Ambulatory
1.5.4 Home Care
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Intravenous (IV) Solutions Market Perspective (2021-2026)
2.2 Intravenous (IV) Solutions Growth Trends by Regions
2.2.1 Intravenous (IV) Solutions Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Intravenous (IV) Solutions Historic Market Size by Regions (2015-2020)
2.2.3 Intravenous (IV) Solutions Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Intravenous (IV) Solutions Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Intravenous (IV) Solutions Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Intravenous (IV) Solutions Average Price by Manufacturers (2015-2020)
4 INTRAVENOUS (IV) SOLUTIONS PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Intravenous (IV) Solutions Market Size (2015-2026)
4.1.2 Intravenous (IV) Solutions Key Players in North America (2015-2020)
4.1.3 North America Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.1.4 North America Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Intravenous (IV) Solutions Market Size (2015-2026)
4.2.2 Intravenous (IV) Solutions Key Players in East Asia (2015-2020)
4.2.3 East Asia Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.2.4 East Asia Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Intravenous (IV) Solutions Market Size (2015-2026)
4.3.2 Intravenous (IV) Solutions Key Players in Europe (2015-2020)
4.3.3 Europe Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.3.4 Europe Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Intravenous (IV) Solutions Market Size (2015-2026)
4.4.2 Intravenous (IV) Solutions Key Players in South Asia (2015-2020)
4.4.3 South Asia Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.4.4 South Asia Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Intravenous (IV) Solutions Market Size (2015-2026)
4.5.2 Intravenous (IV) Solutions Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.5.4 Southeast Asia Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Intravenous (IV) Solutions Market Size (2015-2026)
4.6.2 Intravenous (IV) Solutions Key Players in Middle East (2015-2020)
4.6.3 Middle East Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.6.4 Middle East Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Intravenous (IV) Solutions Market Size (2015-2026)
4.7.2 Intravenous (IV) Solutions Key Players in Africa (2015-2020)
4.7.3 Africa Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.7.4 Africa Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Intravenous (IV) Solutions Market Size (2015-2026)
4.8.2 Intravenous (IV) Solutions Key Players in Oceania (2015-2020)
4.8.3 Oceania Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.8.4 Oceania Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Intravenous (IV) Solutions Market Size (2015-2026)
4.9.2 Intravenous (IV) Solutions Key Players in South America (2015-2020)
4.9.3 South America Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.9.4 South America Intravenous (IV) Solutions Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Intravenous (IV) Solutions Market Size (2015-2026)
4.10.2 Intravenous (IV) Solutions Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Intravenous (IV) Solutions Market Size by Type (2015-2020)
4.10.4 Rest of the World Intravenous (IV) Solutions Market Size by Application (2015-2020)
5 INTRAVENOUS (IV) SOLUTIONS CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Intravenous (IV) Solutions Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Intravenous (IV) Solutions Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Intravenous (IV) Solutions Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Intravenous (IV) Solutions Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Intravenous (IV) Solutions Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Intravenous (IV) Solutions Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Intravenous (IV) Solutions Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Intravenous (IV) Solutions Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Intravenous (IV) Solutions Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Intravenous (IV) Solutions Consumption by Countries
5.10.2 Kazakhstan
6 INTRAVENOUS (IV) SOLUTIONS SALES MARKET BY TYPE (2015-2026)
6.1 Global Intravenous (IV) Solutions Historic Market Size by Type (2015-2020)
6.2 Global Intravenous (IV) Solutions Forecasted Market Size by Type (2021-2026)
7 INTRAVENOUS (IV) SOLUTIONS CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Intravenous (IV) Solutions Historic Market Size by Application (2015-2020)
7.2 Global Intravenous (IV) Solutions Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN INTRAVENOUS (IV) SOLUTIONS BUSINESS
8.1 ICU Medical Inc. (U.S.)
8.1.1 ICU Medical Inc. (U.S.) Company Profile
8.1.2 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product Specification
8.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Baxter (U.S.)
8.2.1 Baxter (U.S.) Company Profile
8.2.2 Baxter (U.S.) Intravenous (IV) Solutions Product Specification
8.2.3 Baxter (U.S.) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 B. Braun Melsungen AG (Germany)
8.3.1 B. Braun Melsungen AG (Germany) Company Profile
8.3.2 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product Specification
8.3.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Grifols S.A. (Spain)
8.4.1 Grifols S.A. (Spain) Company Profile
8.4.2 Grifols S.A. (Spain) Intravenous (IV) Solutions Product Specification
8.4.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Fresenius Kabi AG (Germany)
8.5.1 Fresenius Kabi AG (Germany) Company Profile
8.5.2 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product Specification
8.5.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Terumo Medical Corporation (Tokyo)
8.6.1 Terumo Medical Corporation (Tokyo) Company Profile
8.6.2 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product Specification
8.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Amanta Healthcare (India)
8.7.1 Amanta Healthcare (India) Company Profile
8.7.2 Amanta Healthcare (India) Intravenous (IV) Solutions Product Specification
8.7.3 Amanta Healthcare (India) Intravenous (IV) Solutions Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Intravenous (IV) Solutions (2021-2026)
9.2 Global Forecasted Revenue of Intravenous (IV) Solutions (2021-2026)
9.3 Global Forecasted Price of Intravenous (IV) Solutions (2015-2026)
9.4 Global Forecasted Production of Intravenous (IV) Solutions by Region (2021-2026)
9.4.1 North America Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.3 Europe Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.7 Africa Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.9 South America Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Intravenous (IV) Solutions Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Intravenous (IV) Solutions by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Intravenous (IV) Solutions by Country
10.2 East Asia Market Forecasted Consumption of Intravenous (IV) Solutions by Country
10.3 Europe Market Forecasted Consumption of Intravenous (IV) Solutions by Countriy
10.4 South Asia Forecasted Consumption of Intravenous (IV) Solutions by Country
10.5 Southeast Asia Forecasted Consumption of Intravenous (IV) Solutions by Country
10.6 Middle East Forecasted Consumption of Intravenous (IV) Solutions by Country
10.7 Africa Forecasted Consumption of Intravenous (IV) Solutions by Country
10.8 Oceania Forecasted Consumption of Intravenous (IV) Solutions by Country
10.9 South America Forecasted Consumption of Intravenous (IV) Solutions by Country
10.10 Rest of the world Forecasted Consumption of Intravenous (IV) Solutions by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Intravenous (IV) Solutions Distributors List
11.3 Intravenous (IV) Solutions Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Intravenous (IV) Solutions Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
LIST OF TABLES AND FIGURES
Table 1. Global Intravenous (IV) Solutions Market Share by Type: 2020 VS 2026
Table 2. Peripheral Parenteral Nutrition Features
Table 3. Total Parenteral Nutrition Features
Table 11. Global Intravenous (IV) Solutions Market Share by Application: 2020 VS 2026
Table 12. Hospital & Clinics Case Studies
Table 13. Ambulatory Case Studies
Table 14. Home Care Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Intravenous (IV) Solutions Report Years Considered
Table 29. Global Intravenous (IV) Solutions Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Intravenous (IV) Solutions Market Share by Regions: 2021 VS 2026
Table 31. North America Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 42. East Asia Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 43. Europe Intravenous (IV) Solutions Consumption by Region (2015-2020)
Table 44. South Asia Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 45. Southeast Asia Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 46. Middle East Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 47. Africa Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 48. Oceania Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 49. South America Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 50. Rest of the World Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 51. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product Specification
Table 52. Baxter (U.S.) Intravenous (IV) Solutions Product Specification
Table 53. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product Specification
Table 54. Grifols S.A. (Spain) Intravenous (IV) Solutions Product Specification
Table 55. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product Specification
Table 56. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product Specification
Table 57. Amanta Healthcare (India) Intravenous (IV) Solutions Product Specification
Table 101. Global Intravenous (IV) Solutions Production Forecast by Region (2021-2026)
Table 102. Global Intravenous (IV) Solutions Sales Volume Forecast by Type (2021-2026)
Table 103. Global Intravenous (IV) Solutions Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Intravenous (IV) Solutions Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Intravenous (IV) Solutions Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Intravenous (IV) Solutions Sales Price Forecast by Type (2021-2026)
Table 107. Global Intravenous (IV) Solutions Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Intravenous (IV) Solutions Consumption Value Forecast by Application (2021-2026)
Table 109. North America Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 110. East Asia Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 111. Europe Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 112. South Asia Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 114. Middle East Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 115. Africa Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 116. Oceania Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 117. South America Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 119. Intravenous (IV) Solutions Distributors List
Table 120. Intravenous (IV) Solutions Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 2. North America Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 3. United States Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 4. Canada Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 8. China Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 9. Japan Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 11. Europe Intravenous (IV) Solutions Consumption and Growth Rate
Figure 12. Europe Intravenous (IV) Solutions Consumption Market Share by Region in 2020
Figure 13. Germany Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 15. France Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 16. Italy Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 17. Russia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 18. Spain Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 21. Poland Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Intravenous (IV) Solutions Consumption and Growth Rate
Figure 23. South Asia Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 24. India Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Intravenous (IV) Solutions Consumption and Growth Rate
Figure 28. Southeast Asia Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 29. Indonesia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Intravenous (IV) Solutions Consumption and Growth Rate
Figure 37. Middle East Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 38. Turkey Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 40. Iran Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 42. Israel Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 46. Oman Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 47. Africa Intravenous (IV) Solutions Consumption and Growth Rate
Figure 48. Africa Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 49. Nigeria Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Intravenous (IV) Solutions Consumption and Growth Rate
Figure 55. Oceania Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 56. Australia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 58. South America Intravenous (IV) Solutions Consumption and Growth Rate
Figure 59. South America Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 60. Brazil Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 63. Chile Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 65. Peru Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Intravenous (IV) Solutions Consumption and Growth Rate
Figure 69. Rest of the World Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 71. Global Intravenous (IV) Solutions Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Intravenous (IV) Solutions Price and Trend Forecast (2015-2026)
Figure 74. North America Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 75. North America Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 91. South America Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 95. East Asia Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 96. Europe Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 97. South Asia Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 98. Southeast Asia Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 99. Middle East Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 100. Africa Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 101. Oceania Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 102. South America Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 103. Rest of the world Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Table 1. Global Intravenous (IV) Solutions Market Share by Type: 2020 VS 2026
Table 2. Peripheral Parenteral Nutrition Features
Table 3. Total Parenteral Nutrition Features
Table 11. Global Intravenous (IV) Solutions Market Share by Application: 2020 VS 2026
Table 12. Hospital & Clinics Case Studies
Table 13. Ambulatory Case Studies
Table 14. Home Care Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Intravenous (IV) Solutions Report Years Considered
Table 29. Global Intravenous (IV) Solutions Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Intravenous (IV) Solutions Market Share by Regions: 2021 VS 2026
Table 31. North America Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Intravenous (IV) Solutions Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 42. East Asia Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 43. Europe Intravenous (IV) Solutions Consumption by Region (2015-2020)
Table 44. South Asia Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 45. Southeast Asia Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 46. Middle East Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 47. Africa Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 48. Oceania Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 49. South America Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 50. Rest of the World Intravenous (IV) Solutions Consumption by Countries (2015-2020)
Table 51. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product Specification
Table 52. Baxter (U.S.) Intravenous (IV) Solutions Product Specification
Table 53. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product Specification
Table 54. Grifols S.A. (Spain) Intravenous (IV) Solutions Product Specification
Table 55. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product Specification
Table 56. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product Specification
Table 57. Amanta Healthcare (India) Intravenous (IV) Solutions Product Specification
Table 101. Global Intravenous (IV) Solutions Production Forecast by Region (2021-2026)
Table 102. Global Intravenous (IV) Solutions Sales Volume Forecast by Type (2021-2026)
Table 103. Global Intravenous (IV) Solutions Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Intravenous (IV) Solutions Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Intravenous (IV) Solutions Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Intravenous (IV) Solutions Sales Price Forecast by Type (2021-2026)
Table 107. Global Intravenous (IV) Solutions Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Intravenous (IV) Solutions Consumption Value Forecast by Application (2021-2026)
Table 109. North America Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 110. East Asia Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 111. Europe Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 112. South Asia Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 114. Middle East Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 115. Africa Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 116. Oceania Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 117. South America Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Intravenous (IV) Solutions Consumption Forecast 2021-2026 by Country
Table 119. Intravenous (IV) Solutions Distributors List
Table 120. Intravenous (IV) Solutions Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 2. North America Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 3. United States Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 4. Canada Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 8. China Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 9. Japan Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 11. Europe Intravenous (IV) Solutions Consumption and Growth Rate
Figure 12. Europe Intravenous (IV) Solutions Consumption Market Share by Region in 2020
Figure 13. Germany Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 15. France Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 16. Italy Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 17. Russia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 18. Spain Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 21. Poland Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Intravenous (IV) Solutions Consumption and Growth Rate
Figure 23. South Asia Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 24. India Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Intravenous (IV) Solutions Consumption and Growth Rate
Figure 28. Southeast Asia Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 29. Indonesia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Intravenous (IV) Solutions Consumption and Growth Rate
Figure 37. Middle East Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 38. Turkey Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 40. Iran Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 42. Israel Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 46. Oman Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 47. Africa Intravenous (IV) Solutions Consumption and Growth Rate
Figure 48. Africa Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 49. Nigeria Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Intravenous (IV) Solutions Consumption and Growth Rate
Figure 55. Oceania Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 56. Australia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 58. South America Intravenous (IV) Solutions Consumption and Growth Rate
Figure 59. South America Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 60. Brazil Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 63. Chile Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 65. Peru Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Intravenous (IV) Solutions Consumption and Growth Rate
Figure 69. Rest of the World Intravenous (IV) Solutions Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Intravenous (IV) Solutions Consumption and Growth Rate (2015-2020)
Figure 71. Global Intravenous (IV) Solutions Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Intravenous (IV) Solutions Price and Trend Forecast (2015-2026)
Figure 74. North America Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 75. North America Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 91. South America Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Intravenous (IV) Solutions Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Intravenous (IV) Solutions Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 95. East Asia Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 96. Europe Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 97. South Asia Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 98. Southeast Asia Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 99. Middle East Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 100. Africa Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 101. Oceania Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 102. South America Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 103. Rest of the world Intravenous (IV) Solutions Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
